跳至主要内容
临床试验/NCT02974140
NCT02974140终止不适用

A Prospective, Multicenter, Randomized Evaluation of Refractive Predictability in Patients With or Without Corneal Astigmatism (Maximum Allowable up to 1.25D) When Using the Cataract Refractive Suite and Standard Manual Techniques

Alcon, a Novartis Company4 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2017年3月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
39
试验地点
4
主要终点
Percentage of Eyes With Manifest Refraction Spherical Equivalent (MRSE) Within 0.5 Diopter (D) of Predicted Postoperative Spherical Equivalent at Month 1

研究概览

简要总结

The purpose of this study is to compare the refractive predictability (prediction error) between the Cataract Refractive Suite (CRS) and standard manual technique at one month post-operative

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with bilateral cataracts;
  • Planned cataract surgery and implantation of ReSTOR +2.5 D multifocal intraocular lens (IOL) in both eyes;
  • Clear intraocular media, other than cataract, in study eye(s);
  • Willing and able to complete all required postoperative visits;
  • Able to comprehend and sign a statement of informed consent;
  • Other protocol-specified inclusion criteria may apply.

排除标准

  • Significant irregular corneal astigmatism;
  • History of or current severe dry eyes, retinal/uveal pathology or concurrent ocular disease;
  • Previous intraocular or corneal refractive surgery, corneal transplant, or retinal detachment;
  • Any inflammation or edema (swelling) of the cornea;
  • Pregnant;
  • Other protocol-specified exclusion criteria may apply.

研究组 & 干预措施

CRS

Experimental

First surgical eye randomized to Cataract Refractive Suite with second surgical eye (fellow eye) assigned to standard manual technique. Second eye surgery conducted within 7-14 days of the first eye surgery.

干预措施: Cataract Refractive Suite (CRS) (Device)

CRS

Experimental

First surgical eye randomized to Cataract Refractive Suite with second surgical eye (fellow eye) assigned to standard manual technique. Second eye surgery conducted within 7-14 days of the first eye surgery.

干预措施: Standard manual technique (Procedure)

Manual

Active Comparator

First surgical eye randomized to standard manual technique with second surgical eye (fellow eye) assigned to Cataract Refractive Suite. Second eye surgery conducted within 7-14 days of the first eye surgery.

干预措施: Cataract Refractive Suite (CRS) (Device)

Manual

Active Comparator

First surgical eye randomized to standard manual technique with second surgical eye (fellow eye) assigned to Cataract Refractive Suite. Second eye surgery conducted within 7-14 days of the first eye surgery.

干预措施: Standard manual technique (Procedure)

结局指标

主要结局

Percentage of Eyes With Manifest Refraction Spherical Equivalent (MRSE) Within 0.5 Diopter (D) of Predicted Postoperative Spherical Equivalent at Month 1

时间窗: Day 20-40 from second implantation

Manifest refraction spherical equivalent (MRSE) was calculated as follows: sphere + 1/2 cylinder. The sphere and cylinder values were from the manifest refraction assessment. Manifest refraction was assessed at 4 meters under photopic lighting conditions using a phoropter. Due to early termination of the study and limited sample size, a statistical inference test was not carried out as planned.

次要结局

  • Estimated Aspiration Fluid Used During Surgery(Day 0 (operative day), each eye)
  • Cumulative Dissipated Energy (CDE)(Day 0 (operative day), each eye)
  • Phaco Aspiration Time Spent During Surgery(Day 0 (operative day), each eye)

研究者

发起方
Alcon, a Novartis Company
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验